Morbidity and Mortality in Patients Undergoing Mitral Valve Replacement at a Cardiovascular Surgery Referral Service:

Júlia Lasserre Moreira1, Pedro Henrique Andrade Araújo Salvatore Barletta1, José Augusto Baucia2

  • 1Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Insights

Predictors of death after mitral valve replacement include older age, reduced ejection fraction (EF), and mitral regurgitation (MR). These factors are crucial for improving patient outcomes in cardiovascular surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Surgery
  • Medical Research

Background:

  • Mitral valve replacement is a critical procedure for patients with severe mitral valve disease.
  • Identifying factors influencing outcomes is essential for surgical planning and patient management.

Purpose of the Study:

  • To identify predictors of morbidity and mortality in patients undergoing isolated mitral valve replacement.
  • To analyze the impact of preoperative, intraoperative, and postoperative factors on patient outcomes.

Main Methods:

  • Retrospective cohort study of 164 patients undergoing isolated mitral valve replacement (2011-2016).
  • Data collected from medical records, including demographics, diagnoses, and surgical details.
  • Statistical analysis using odds ratio (OR) and binary logistic regression.

Main Results:

  • Mortality rate was 6.7%; common complication was postoperative arrhythmias (19.5%).
  • Significant risk factors for death included endocarditis, reduced ejection fraction (EF) (<50%), and mitral regurgitation (MR).
  • Older age and lower preoperative hemoglobin levels were associated with increased mortality.

Conclusions:

  • Older age and reduced preoperative ejection fraction (EF) are significant predictors of death after mitral valve replacement.
  • Preoperative endocarditis and mitral regurgitation (MR) are also associated with increased postoperative mortality.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
117
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
146
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
128
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
169
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
166
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
180